Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02179918 |
Title | A Study Of 4-1BB Agonist PF-05082566 Plus PD-1 Inhibitor MK-3475 In Patients With Solid Tumors (B1641003/KEYNOTE-0036) |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Pfizer |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Research Administration Office | Los Angeles | California | 90095 | United States | Details | |
Ronald Reagan UCLA Medical Center, Drug Information Center | Los Angeles | California | 90095 | United States | Details | |
UCLA Hematology-Oncology Clinic | Los Angeles | California | 90095 | United States | Details | |
UCLA Oncology Center | Los Angeles | California | 90095 | United States | Details | |
Smilow Cancer Center at Yale-New Haven Hospital | New Haven | Connecticut | 06510 | United States | Details | |
Smilow Cancer Hospital at Yale-New Haven | New Haven | Connecticut | 06510 | United States | Details | |
South Texas Accelerated Research Therapeutics, LLC | San Antonio | Texas | 78229 | United States | Details | |
Seattle Cancer Care Alliance | Seattle | Washington | 98109 | United States | Details | |
University of Washington Medical Center | Seattle | Washington | 98195 | United States | Details |